Ozempic Keeps Wowing: Trial Data Show Benefits for Kidney Disease

May 24, 2024

3 hypodermic needles

(Nature) – The blockbuster diabetes drug Ozempic — also sold as the obesity drug Wegovy — can add another health condition to the list of maladies it alleviates. Researchers presented clinical-trial data today at a conference in Stockholm, showing that it significantly reduces the risk of kidney failure and death for people with type 2 diabetes and chronic kidney disease. Scientists are thrilled with the result, and think that the drug, otherwise known by its generic name, semaglutide, will eventually be proved to help a more general population of people with kidney disease. This trial is a first step towards that goal, they say. (Read More)

Recommended Reading